Literature DB >> 24646774

Normothermic regional perfusion for donation after circulatory death without prior heparinization.

Andrew J Butler1, Lucy V Randle, Christopher Je Watson.   

Abstract

BACKGROUND: Over 40% of deceased donors in the UK donate after circulatory death (DCD). Normothermic regional perfusion has been reported to improve outcomes in such donors in Europe and the United States. Unlike the United States, legal and professional requirements in the UK prevent cannulation and heparinization before verification of death, which must be a minimum of 5 min after circulatory arrest. We developed a novel protocol for in situ normothermic regional perfusion (NRP) which complied with these requirements.
METHODS: NRP was achieved by cannulating the aorta and vena cava after death. Donor blood was then warmed and oxygenated using a bespoke extracorporeal membrane oxygenator circuit before return to the donor. A shunt was incorporated into the extracorporeal circuit to permit heparin mixing before oxygenation and warming was commenced to prevent thrombosis of the oxygenator. Normothermic perfusion was continued for 2 hr before in situ cold perfusion with preservation fluid. All organs were subject to static cold storage after recovery.
RESULTS: Eight controlled DCD donors underwent NRP from which 3 livers, 2 pancreases, and 14 kidneys were transplanted. Four livers were not used because of biochemical evidence of hepatocellular damage and one because of cirrhosis. Two kidneys were lost from venous thrombosis before function returned and two developed delayed graft function; all transplanted livers and pancreases had primary function.
CONCLUSIONS: Cannulation and heparinization after circulatory arrest does not prevent successful normothermic regional perfusion. The technique permits evaluation of donor organs before implantation and may improve short-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646774     DOI: 10.1097/TP.0000000000000082

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Cyclic Helix B Peptide in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia-Reperfusion Injury in Isolated Porcine Kidneys.

Authors:  Cheng Yang; Sarah A Hosgood; Patel Meeta; Yaqiu Long; Tongyu Zhu; Michael L Nicholson; Bin Yang
Journal:  Transplant Direct       Date:  2015-03-10

Review 2.  Machine perfusion in abdominal organ transplantation: Current use in the Netherlands.

Authors:  Elsaline Rijkse; Jan Nm IJzermans; Robert C Minnee
Journal:  World J Transplant       Date:  2020-01-18

Review 3.  Complications during multiorgan retrieval and pancreas preservation.

Authors:  Daniel Casanova; Gonzalo Gutierrez; Monica Gonzalez Noriega; Federico Castillo
Journal:  World J Transplant       Date:  2020-12-28

4.  Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death.

Authors:  Marilena Gregorini; Elena Ticozzelli; Massimo Abelli; Maria A Grignano; Eleonora F Pattonieri; Alessandro Giacomoni; Luciano De Carlis; Antonio Dell'Acqua; Rossana Caldara; Carlo Socci; Andrea Bottazzi; Carmelo Libetta; Vincenzo Sepe; Stefano Malabarba; Federica Manzoni; Catherine Klersy; Giuseppe Piccolo; Teresa Rampino
Journal:  Transpl Int       Date:  2022-02-08       Impact factor: 3.782

5.  Kidney Transplants in Controlled Donation Following Circulatory Death, or Maastricht Type III Donors, With Abdominal Normothermic Regional Perfusion, Optimizing Functional Outcomes.

Authors:  Patricia Ramirez; David Vázquez; Gabriel Rodríguez; Juan José Rubio; Marina Pérez; Jose Maria Portolés; Joaquín Carballido
Journal:  Transplant Direct       Date:  2021-07-16

Review 6.  Challenges and advances in optimizing liver allografts from donation after circulatory death donors.

Authors:  Andrew Ian Sutherland; Gabriel C Oniscu
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.